Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spanish research identifies blood test for stroke progression

This article was originally published in Clinica

Executive Summary

A simple blood test which predicts the likelihood of a stroke progressing has been identified by a team of Spanish researchers. The test measures the concentration of an aminoacid called glutamate in blood plasma which is normally stored in brain cells and is used as a neurotransmitter. Stroke-damaged brain cells are believed to release large amounts of glutamate into the blood stream when they die. Neighbouring brain cells, which were initially spared during the initiation of the stroke, may be poisoned and thereby killed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT084499

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel